2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow GC1113: new trials by email Literature Review of GC1113 trials Research Report on GC1113
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GX-E2 in Healthy Subjects GX-E2 - Healthy | Phase 1 | Completed | Genexine, Inc. | 10 | 2014-11-01 | 2015-01-29 |
| To Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Erythropoietin GC1113, Darbepoetin alfa - Healthy Volunteer | Phase 1 | Completed | Green Cross Corporation | 100 | 2011-06-01 | 2012-07-19 |
Genexine, Inc. (1) · Green Cross Corporation (1)
South Korea (1)
Kyung-Sang Yu, MD., Ph.D (1) · KyungSang Yu, M.D. (1)